GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (OSL:BGBIO) » Definitions » Dividend-Payout-to-FFO

BerGenBio ASA (OSL:BGBIO) Dividend-Payout-to-FFO


View and export this data going back to 2017. Start your Free Trial

What is BerGenBio ASA Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


BerGenBio ASA (OSL:BGBIO) Business Description

Traded in Other Exchanges
Address
Mollendalsbakken 9, Bergen, NOR, 5009
BerGenBio ASA is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is d is curently being developed in STK11 mutated NSCLC and severe respiratory infections including COVID-19. .